A Double-Blind, Parallel Group, Comparative Study of Intravenous S-021812 in Patients with Influenza Virus Infectio
Phase 3
- Conditions
- influenza virus infection
- Registration Number
- JPRN-jRCT2080220735
- Lead Sponsor
- SHIONOGI & CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
The patient who diagnosed with influenza virus infection
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method